LFB USA is a company within the LFB Group, a leading European biopharmaceutical company specialized in innovative biotherapies, marketing its medicinal products around the world.

LFB USA has a key role in developing LFB's pipeline in the US, focusing on research, clinical development and regulatory strategies and filings. For the Factor FVIIa (LR769) program, LFB USA …

Framingham biopharmaceutical firm LFB USA has pinned plans to build a new 65,000-square-foot manufacturing and laboratory facility in Marlborough in part on the expectation that its drug, ATryn, …

At LFB USA, we are powering the development and commercialization of highly innovative recombinant therapies to address an ever-growing set of unmet medical needs. To do this effectively, we …

The proprietary rPRO Technology ™ that drives LFB S.A.'s product development enables production of innovative recombinant therapies that are more cost-effective and scalable compared to traditionally …

LFB USA is about challenging yourself. It’s about applying science and resources to meet unmet needs. It’s about succeeding as an individual and as part of a team. We are at the forefront of recombinant …

LFB USA is a globalized company which develops and provides pharmaceutical bioproducts through its innovative technologies for patients with serious diseases. LFB USA is committed to overcoming …

Contact Corporate headquarters for LFB USA: LFB USA, Inc. 175 Crossing Blvd. Framingham, MA 01702

LFB USA is focused on developing and commercializing life-changing and life-saving therapies for patients, particularly in the area of rare diseases. We’re committed to reaching more patients with …

LFB USA is led by a team of business experts and scientists with a successful track record of developing and commercializing important and highly innovative healthcare technologies and life …